OnCore Login

Return to Trial Database

LUN05-99

Paclitaxel Plus Bevacizumab in Patients With Chemosensitive Relapsed Small Cell Lung Cancer (SCLC): A Safety, Feasibility and Efficacy Study

Status

Study Completed

Cancer Type(s)

Lung

Study Contact

Publications

Paclitaxel (P) plus bevacizumab (B) in patients (pts) with Chemosensitive Relapsed Small Cell Lung Cancer (SCLC): A Safety, Feasibility and Efficacy trial
  • S Jalal, S Bhatia, L Einhorn, R Ansari, N Bechar, R Govindan, K Koneru, P Bedano, J Wu, N Hanna
Paclitaxel Plus Bevacizumab in Patients with Chemosensitive Relapsed Small Cell Lung Cancer: A Safety, Feasibility, and Efficacy Study
  • S Jalal, P Bedano, L Einhorn, S Bhatia, R Ansari, N Bechar, K Koneru, R Govindan, J Wu, M Yu, B Schneider, N Hanna

Trial Locations

All sites in which the trial LUN05-99 being conducted in.
No data was found
  • 7676 Interactive Way, Suite 120, Indianapolis, IN 46278